Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis
Author(s):
Heijde, D. van der; Zack, D.; Wajdula, J.; Sridharan, S.; Koenig, A.S.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-12-31
Language
English
Is part of
Scandinavian Journal of Rheumatology (2014), Vol. 43, no. 1, p. 49-53
